This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martins, L. M.
Right arrow Articles by Downward, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martins, L. M.
Right arrow Articles by Downward, J.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 2004, p. 9848-9862, Vol. 24, No. 22
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.22.9848-9862.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Neuroprotective Role of the Reaper-Related Serine Protease HtrA2/Omi Revealed by Targeted Deletion in Mice

L. Miguel Martins,1,2 Alastair Morrison,3 Kristina Klupsch,1 Valentina Fedele,2 Nicoleta Moisoi,2 Peter Teismann,4 Alejandro Abuin,3 Evelyn Grau,3 Martin Geppert,3 George P. Livi,5 Caretha L. Creasy,5 Alison Martin,1 Iain Hargreaves,6 Simon J. Heales,6 Hitoshi Okada,7 Sebastian Brandner,8 Jörg B. Schulz,4 Tak Mak,7 and Julian Downward1*

Signal Transduction Laboratory, Cancer Research UK London Research Institute,1 Neurometabolic Unit,6 Division of Neuropathology and Department of Neurodegenerative Disease,8 Institute of Neurology, London, Cell Death Regulation Laboratory, MRC Toxicology Unit, Leicester,2 Department of Comparative Genomics, GlaxoSmithKline, Harlow, Essex, United Kingdom,3 Department of Comparative Genomics, GlaxoSmithKline, Upper Providence, Philadelphia, Pennsylvania,5 Department of Neurodegeneration and Neurorestoration, Center of Neurology and Center of Molecular Physiology of the Brain, University of Göttingen, Göttingen, Germany,4 Division of Cellular and Molecular Biology, AMDI Institute, Toronto, Ontario, Canada7

Received 4 August 2004/ Accepted 10 August 2004

The serine protease HtrA2/Omi is released from the mitochondrial intermembrane space following apoptotic stimuli. Once in the cytosol, HtrA2/Omi has been implicated in promoting cell death by binding to inhibitor of apoptosis proteins (IAPs) via its amino-terminal Reaper-related motif, thus inducing caspase activity, and also in mediating caspase-independent death through its own protease activity. We report here the phenotype of mice entirely lacking expression of HtrA2/Omi due to targeted deletion of its gene, Prss25. These animals, or cells derived from them, show no evidence of reduced rates of cell death but on the contrary suffer loss of a population of neurons in the striatum, resulting in a neurodegenerative disorder with a parkinsonian phenotype that leads to death of the mice around 30 days after birth. The phenotype of these mice suggests that it is the protease function of this protein and not its IAP binding motif that is critical. This conclusion is reinforced by the finding that simultaneous deletion of the other major IAP binding protein, Smac/DIABLO, does not obviously alter the phenotype of HtrA2/Omi knockout mice or cells derived from them. Mammalian HtrA2/Omi is therefore likely to function in vivo in a manner similar to that of its bacterial homologues DegS and DegP, which are involved in protection against cell stress, and not like the proapoptotic Reaper family proteins in Drosophila melanogaster.


* Corresponding author. Mailing address: Cancer Research UK London Research Institute, Signal Transduction Laboratory, 44 Lincoln's Inn Fields, London WC2A 3PX, United Kingdom. Phone: 44-20-7269-3533. Fax: 44-20-7269-3094. E-mail: julian.downward{at}cancer.org.uk.


Molecular and Cellular Biology, November 2004, p. 9848-9862, Vol. 24, No. 22
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.22.9848-9862.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Liu, M.-L., Liu, M.-J., Shen, Y.-F., Ryu, H., Kim, H.-J., Klupsch, K., Downward, J., Hong, S.-T. (2009). Omi is a mammalian heat-shock protein that selectively binds and detoxifies oligomeric amyloid-{beta}. J. Cell Sci. 122: 1917-1926 [Abstract] [Full Text]  
  • Lesage, S., Brice, A. (2009). Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 18: R48-R59 [Abstract] [Full Text]  
  • Padmanabhan, N., Fichtner, L., Dickmanns, A., Ficner, R., Schulz, J. B., Braus, G. H. (2009). The Yeast HtrA Orthologue Ynm3 Is a Protease with Chaperone Activity that Aids Survival Under Heat Stress. Mol. Biol. Cell 20: 68-77 [Abstract] [Full Text]  
  • Yun, J., Cao, J. H., Dodson, M. W., Clark, I. E., Kapahi, P., Chowdhury, R. B., Guo, M. (2008). Loss-of-Function Analysis Suggests That Omi/HtrA2 Is Not an Essential Component of the pink1/parkin Pathway In Vivo. J. Neurosci. 28: 14500-14510 [Abstract] [Full Text]  
  • Krick, S., Shi, S., Ju, W., Faul, C., Tsai, S.-y., Mundel, P., Bottinger, E. P. (2008). Mpv17l protects against mitochondrial oxidative stress and apoptosis by activation of Omi/HtrA2 protease. Proc. Natl. Acad. Sci. USA 105: 14106-14111 [Abstract] [Full Text]  
  • Schile, A. J., Garcia-Fernandez, M., Steller, H. (2008). Regulation of apoptosis by XIAP ubiquitin-ligase activity. Genes Dev. 22: 2256-2266 [Abstract] [Full Text]  
  • Simon-Sanchez, J., Singleton, A. B. (2008). Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls. Hum Mol Genet 17: 1988-1993 [Abstract] [Full Text]  
  • Stichel, C. C., Zhu, X.-R., Bader, V., Linnartz, B., Schmidt, S., Lubbert, H. (2007). Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage. Hum Mol Genet 16: 2377-2393 [Abstract] [Full Text]  
  • Huttunen, H. J., Guenette, S. Y., Peach, C., Greco, C., Xia, W., Kim, D. Y., Barren, C., Tanzi, R. E., Kovacs, D. M. (2007). HtrA2 Regulates beta-Amyloid Precursor Protein (APP) Metabolism through Endoplasmic Reticulum-associated Degradation. J. Biol. Chem. 282: 28285-28295 [Abstract] [Full Text]  
  • Ho, A. T., Li, Q. H., Okada, H., Mak, T. W., Zacksenhaus, E. (2007). XIAP Activity Dictates Apaf-1 Dependency for Caspase 9 Activation. Mol. Cell. Biol. 27: 5673-5685 [Abstract] [Full Text]  
  • Yang, L., Sun, M., Sun, X.-m., Cheng, G. Z., Nicosia, S. V., Cheng, J. Q. (2007). Akt Attenuation of the Serine Protease Activity of HtrA2/Omi through Phosphorylation of Serine 212. J. Biol. Chem. 282: 10981-10987 [Abstract] [Full Text]  
  • Kroemer, G., Galluzzi, L., Brenner, C. (2007). Mitochondrial Membrane Permeabilization in Cell Death. Physiol. Rev. 87: 99-163 [Abstract] [Full Text]  
  • Park, H.-J., Kim, S.-S., Seong, Y.-M., Kim, K.-H., Goo, H. G., Yoon, E. J., Min, D. S., Kang, S., Rhim, H. (2006). beta-Amyloid Precursor Protein Is a Direct Cleavage Target of HtrA2 Serine Protease: IMPLICATIONS FOR THE PHYSIOLOGICAL FUNCTION OF HtrA2 IN THE MITOCHONDRIA. J. Biol. Chem. 281: 34277-34287 [Abstract] [Full Text]  
  • Munoz-Pinedo, C., Guio-Carrion, A., Goldstein, J. C., Fitzgerald, P., Newmeyer, D. D., Green, D. R. (2006). Different mitochondrial intermembrane space proteins are released during apoptosis in a manner that is coordinately initiated but can vary in duration. Proc. Natl. Acad. Sci. USA 103: 11573-11578 [Abstract] [Full Text]  
  • Strauss, K. M., Martins, L. M., Plun-Favreau, H., Marx, F. P., Kautzmann, S., Berg, D., Gasser, T., Wszolek, Z., Muller, T., Bornemann, A., Wolburg, H., Downward, J., Riess, O., Schulz, J. B., Kruger, R. (2005). Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet 14: 2099-2111 [Abstract] [Full Text]